Navigation Links
Access Pharmaceuticals Receives Letter of Acceptance For MuGard Filing From SFDA of China
Date:6/17/2011

Access retains its existing milestone and royalty structure for the territory.  

"The acceptance of MuGard submission is a critical step in receiving marketing approval for MuGard in China and South East Asian territories," said Phillip Wise, Vice President of Business Development and Strategy, Access Pharmaceuticals, Inc.  He continued, "We knew that the SFDA would perform a significant amount of due diligence before it would accept our MuGard submission.  Receiving the acceptance letter helps us, as a company, gauge more accurately the timeline to marketing approval.  We are pleased with RHEI and Jian An's ability to streamline the process thus far and their continued progress and commitment to advancing the marketing approval."  

About MuGard:MuGard is a novel; ready-to-use mucoadhesive oral wound rinse and coating for the management of oral mucositis, a debilitating side effect of many anticancer treatments. Up to 40% of all patients receiving chemotherapy and radiotherapy develop moderate to severe mucositis, and almost all patients receiving radiotherapy for head and neck cancer and those undergoing stem cell transplantation develop mucositis. Updated clinical practice guidelines for the prevention and treatment of mucositis recommend the use of a preventive oral care regimen as part of routine supportive care along with a therapeutic oral care regimen if mucositis develops. The market for the treatment of oral mucositis is estimated to be in excess of $1 billion world-wide.  For more information, please visit www.MuGard.com.

About RHEI Pharmaceuticals:RHEI Pharmaceuticals is a specialty pharmaceutical company with operations in the U.S. and in China that acquires licenses, develops and commercializes in China proprietary drug therapies
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 29, 2015  New guidelines released today by ... give hope for better outcomes to the hundreds ... ischemic stroke each year. Stryker,s Trevo ® ... in the clinical trials that provided data for ... strongly recommend endovascular therapy with stent retrievers for ...
(Date:6/29/2015)... PAUL, Minn. , June 29, 2015 ... manufacturer of devices that use neuroblocking technology to treat ... that it has commenced an underwritten public offering of ... common stock, Series A warrants to purchase common stock ... whose purchase of units in the offering would result ...
(Date:6/29/2015)... Sciences, Inc. (NASDAQ: ALIM ) (Alimera), a pharmaceutical ... of prescription ophthalmic pharmaceuticals, today announced that Rick ... will present at the 2015 Cantor Fitzgerald Inaugural Healthcare ... at Le Parker Meridien Hotel in New ... webcast live and will be available for access, along ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3
... , ATLANTA , Feb. 8 ... an Atlanta -based, biopharmaceutical company developing human vaccines for ... agents, today provided an update on its vaccine trials progress. ... rate, 60,000 new infections annually, and that,s just in ...
... , PORTLAND, Ore. , Feb. 8 ... use of localized content by sales teams. Together, the companies ... translated content to reach the hands of global sales professionals ... sales cycle. This combination gives the sales person the right ...
Cached Medicine Technology:GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 2GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 3GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 4GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 5GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 6Prolifiq and viaLanguage Announce Partnership: Accelerate the Use of Localized Content by Sales Teams 2Prolifiq and viaLanguage Announce Partnership: Accelerate the Use of Localized Content by Sales Teams 3
(Date:6/30/2015)... , ... June 30, 2015 , ... ... June 24, 2015 amidst bright skies and inspirational words. , The independent, ... processional walk from the Glenholme building to the school’s Center for the Arts. ...
(Date:6/30/2015)... Falls Church, VA (PRWEB) , ... June 30, ... ... (APNA) 29th Annual Conference will be held October 28-31, 2015 at Disney’s Coronado ... days of continuing nursing education and networking. Each year, this premiere event for ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Americans report ... from the buzzer on Monday mornings, which puts stressed out people right over the ... week, with 22% suffering from sleep deprivation every night. Sleeping pills now lead the ...
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... “It ... and founder of SunGrubbies.com. “We are particularly interested in getting the word out ... take years to surface. We are extremely pleased with our new video ...
(Date:6/29/2015)... ... ... Aespala Medspa and Plastic Surgery is proud to introduce the newest member ... Dreyfuss received his medical degree from Emory University in Atlanta before completing a General ... at the University of Chicago. He has taught and practiced medicine in the Chicago ...
Breaking Medicine News(10 mins):Health News:The Glenholme School Graduates Its Class of 2015 2Health News:The Glenholme School Graduates Its Class of 2015 3Health News:The Glenholme School Graduates Its Class of 2015 4Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 3Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 3
... CHAPEL HILL, N.C., April 4, 2008 Companies ... For a,company with an annual sales volume of ... are assigned to the early-stage commercialization team along,with ... volumes, the ratio is approximately four to three, ...
... are five-to-six times more likely to be at serious risk ... early as their teenage years, according to a new study ... Hill. , The findings, published Friday (April 4) in the ... children twice first while in grade school, then again ...
... More than 54 million American,adults have prediabetes, ... to live,with diabetes and all of its health ... created by Kronos Optimal Health,Company. It is estimated ... with manageable lifestyle choices., "When someone is ...
... but not mother,s, weight and elevated enzymes , , THURSDAY, ... early-onset obesity are at increased risk for elevated liver ... , Researchers evaluated 1,732 children, average age 42, of ... of families in Framingham, Mass. The researchers found that ...
... Two Doses Against the Most ... Rotavirus Types in the U.S., PHILADELPHIA, April 3, ... the U.S. Food and Drug Administration,(FDA) has approved ROTARIX(R) ... in infants. ROTARIX will offer,protection against the most commonly ...
... outcome of ,terrible 2s, battles but not frequency, ... The way mothers and their 2-year-olds relate to each ... -- of conflict during the "terrible twos." And a ... frequency of such conflicts, according to a new study. ...
Cached Medicine News:Health News:Early-stage Commercialization Success: Pharma Companies Adjust Resources in Light of Industry Changes 2Health News:Inactive kids face 6-fold risk of heart disease by teen years, study finds 2Health News:Kronos Optimal Health Company Aims to Stop Diabetes Before It Starts 2Health News:Dads' Early-Onset Obesity Linked to Liver Disease in Kids 2Health News:FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE 2Health News:FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE 3Health News:FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE 4Health News:FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE 5Health News:Mother-Child Bond Affects Quality of Conflict Resolution 2
Inquire...
... Tips offer a safe alternative to using ... for applications such as PCR(a), pipetting radioactive ... Tips are excellent for tissue culture, gel ... Tips prevent aerosol contaminants and liquids from ...
... Eliminate aerosol contamination, ... reactions in PCR. Hydrophobic, ... Only air can pass ... tips, in contrast to ...
... Finntip Filters are ideal ... methods, or for any work ... They are designed for pipetting ... samples, and other. For applications ...
Medicine Products: